All of the above provides support to the notion that BCR-ABLp210-provoked changes to the epigenome “fix” the lineage identity of the transformed HSC and its progeny leukaemia cells to that of myeloid development [reviewed in 65]. The gene discussed is BCR; the disease is leukemia.